The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital

被引:4
作者
Sinha, Anil-Martin [1 ,2 ]
Bense, Jens [1 ,2 ]
Hohenforst-Schmidt, Wolfgang [1 ,2 ]
机构
[1] Sana Klinikum Hof, Dept Cardiol, Eppenreuther Str 9, D-95032 Hof, Germany
[2] Friedrich Alexander Univ Erlangen, Teaching Hosp, Dept Cardiol, Erlangen, Germany
关键词
Arrhythmia; Cardiomyopathy; Implantable cardioverter-defibrillator; Sudden cardiac arrest; Sudden cardiac death; Wearable cardioverter-defibrillator; CARDIAC-ARREST; HIGH-RISK; VENTRICULAR-ARRHYTHMIAS; PREVENTION; EXPERIENCE; URBAN;
D O I
10.1007/s10840-020-00898-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Large-scale multi-center studies have reported on efficacy of the wearable cardioverter-defibrillator (WCD). However, outcomes focused on WCD patients treated at community-based acute care centers are lacking. Methods Patients with cardiomyopathy were included when left ventricular ejection fraction (LVEF) at baseline was <= 35%. There were 120 patients meeting the criteria who also had LVEF measured at baseline and after 90 days of WCD use. Results After 90 days of WCD use, there were 44 (37%) patients in whom LVEF improved to > 35%. Comparison of patients, by whether LVEF improved or not, indicated that median days of WCD wear and hours of daily use were similar as well as characteristics, such as gender, age, and starting LVEF; and diagnoses leading to WCD prescription were similar between groups as were symptom-based prescription of medications. At the end of WCD use, improved LVEF > 35% correlated with fewer implantable cardioverter-defibrillator (ICD) implants. There were 4 (3%) episodes of new atrial fibrillation detected during WCD use. The WCD appropriately delivered a shock to 3 (2.5%) patients with VT/VF being terminated by the first shock. All shocked patients survived for at least 24 h post-shock. Conclusions During WCD use, ischemic and non-ischemic cardiomyopathy patients manifest improved LVEF by 90 days. Long-term care decisions, such as implantation of an ICD, were influenced by LVEF improvement and occurrence of spontaneous VT/VF. The WCD protected patients from sudden cardiac death (SCD) until patient response to guideline-directed medical therapy could be determined.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 17 条
[1]   STATISTICS NOTES - ABSENCE OF EVIDENCE IS NOT EVIDENCE OF ABSENCE [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1995, 311 (7003) :485-485
[2]   Home use of automated external defibrillators for sudden cardiac arrest [J].
Bardy, Gust H. ;
Lee, Kerry L. ;
Mark, Daniel B. ;
Poole, Jeanne E. ;
Toff, William D. ;
Tonkin, Andrew M. ;
Smith, Warren ;
Dorian, Paul ;
Packer, Douglas L. ;
White, Roger D. ;
Longstreth, W. T., Jr. ;
Anderson, Jill ;
Johnson, George ;
Bischoff, Eric ;
Yallop, Julie J. ;
McNulty, Steven ;
Ray, Linda Davidson ;
Clapp-Channing, Nancy E. ;
Rosenberg, Yves ;
Schron, Eleanor B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (17) :1793-1804
[3]   Aggregate National Experience With the Wearable Cardioverter-Defibrillator Event Rates, Compliance, and Survival [J].
Chung, Mina K. ;
Szymkiewicz, Steven J. ;
Shao, Mingyuan ;
Zishiri, Edwin ;
Niebauer, Mark J. ;
Lindsay, Bruce D. ;
Tchou, Patrick J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (03) :194-203
[4]   Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study [J].
Duncker, David ;
Koenig, Thorben ;
Hohmann, Stephan ;
Bauersachs, Johann ;
Veltmann, Christian .
CLINICAL CARDIOLOGY, 2017, 40 (08) :586-590
[5]   Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study [J].
Duncker, David ;
Koenig, Thorben ;
Hohmann, Stephan ;
Bauersachs, Johann ;
Veltmann, Christian .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (01)
[6]   Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction [J].
Epstein, Andrew E. ;
Abraham, William T. ;
Bianco, Nicole R. ;
Kern, Karl B. ;
Mirro, Michael ;
Rao, Sunil V. ;
Rhee, Edward K. ;
Solomon, Scott D. ;
Szymkiewicz, Steven J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (21) :2000-2007
[7]   Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of WEARIT/BIROAD [J].
Feldman, AM ;
Klein, H ;
Tchou, P ;
Murali, S ;
Hall, WJ ;
Mancini, D ;
Boehmer, J ;
Harvey, M ;
Hellman, MS ;
Szymkiewicz, SJ ;
Moss, AJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (01) :4-9
[8]   Another Shock for Sudden Death Prevention after Myocardial Infarction [J].
Field, Michael E. ;
Page, Richard L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (13) :1274-1275
[9]   Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry) [J].
Kutyifa, Valentina ;
Moss, Arthur J. ;
Klein, Helmut ;
Biton, Yitschak ;
McNitt, Scott ;
MacKecknie, Bonnie ;
Zareba, Wojciech ;
Goldenberg, Ilan .
CIRCULATION, 2015, 132 (17) :1613-1619
[10]   PREDICTING SURVIVAL FROM OUT-OF-HOSPITAL CARDIAC-ARREST - A GRAPHIC MODEL [J].
LARSEN, MP ;
EISENBERG, MS ;
CUMMINS, RO ;
HALLSTROM, AP .
ANNALS OF EMERGENCY MEDICINE, 1993, 22 (11) :1652-1658